Repository logo
 
Publication

Medication use for the management of professional performance: between invisibility and social normalisation

dc.contributor.authorLopes, Noémia
dc.contributor.authorTavares, David
dc.contributor.authorPegado, Elsa
dc.contributor.authorRaposo, Hélder António
dc.contributor.authorRodrigues, Carla
dc.date.accessioned2024-07-24T08:59:45Z
dc.date.available2024-07-24T08:59:45Z
dc.date.issued2024-11
dc.descriptionThe study was supported by the Portuguese Foundation for Science and Technology (FCT)under Grant (PTDC/SOC/30734/2017), and hosted by the research centre CIES, Iscte-Insti-tuto Universitário de Lisboa [University Institute of Lisbon], in partnership with Egas MonizSchool of Health & Science and the Instituto de Sociologia da Universidade do Porto [Insti-tute of Sociology of the University of Porto].pt_PT
dc.description.abstractThis article aims to explore pharmaceuticalisation processes in professional work contexts. The approach focuses on identifying patterns of medicine and dietary supplement use for managing work performance, and on discussing the relationship between these consumption practices and work-related pressure factors. This analysis adapts the notions of 'normalisation' to understand the extent of cultural acceptability of these practices, and the notion of 'differentiated normalisation' to capture the tension between the trend towards normalisation of such consumption and its partial social (in)visibility within work settings. Empirical support for this analysis is based on a sociological study conducted in Portugal on professions under high performance pressures. The study involved three professional groups - nurses, journalists and police officers. A mixed methods approach was used, including focus groups, questionnaires and semi-structured interviews. Overall, the results show a trend towards the use of medicines and supplements for performance management, which reveals itself as a cultural response to work-related social pressures. Such consumption coexists with irregular patterns of either occasional or long-term use, as well as heterogeneous processes of 'normalisation' and 'hidden' consumption. Conclusions point to a social interconnection between the intensification of work pressures and the pharmaceuticalisation of work performance.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationLopes N, Tavares D, Pegado E, Raposo H, Rodrigues C. Medication use for the management of professional performance: between invisibility and social normalization. Health Soc Rev. 2024;33(3):358-75.pt_PT
dc.identifier.doi10.1080/14461242.2024.2362174pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.21/17581
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherTaylor & Francispt_PT
dc.relationMedicines and dietary supplements in performance consumptions: social practices, contexts and literacy
dc.relation.publisherversionhttps://www.tandfonline.com/doi/full/10.1080/14461242.2024.2362174pt_PT
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/pt_PT
dc.subjectMedicationpt_PT
dc.subjectDifferentiated normalisationpt_PT
dc.subjectPerformance consumptionspt_PT
dc.subjectPharmaceuticalisationpt_PT
dc.subjectProfessional pressurept_PT
dc.subjectWork contextspt_PT
dc.subjectSociology of healthpt_PT
dc.subjectFCT_PTDC/SOC-SOC/30734/2017pt_PT
dc.titleMedication use for the management of professional performance: between invisibility and social normalisationpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardTitleMedicines and dietary supplements in performance consumptions: social practices, contexts and literacy
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FSOC-SOC%2F30734%2F2017/PT
oaire.citation.endPage18pt_PT
oaire.citation.endPage375pt_PT
oaire.citation.issue3pt_PT
oaire.citation.startPage1pt_PT
oaire.citation.startPage358pt_PT
oaire.citation.titleHealth Sociology Reviewpt_PT
oaire.citation.volume33pt_PT
oaire.fundingStream3599-PPCDT
person.familyNameTavares
person.familyNameRaposo
person.givenNameDavid
person.givenNameHélder António
person.identifier2254036
person.identifier.ciencia-idEA11-B1BB-2FE3
person.identifier.ciencia-idC91C-9AF3-4B33
person.identifier.orcid0000-0003-4473-8595
person.identifier.orcid0000-0002-3614-5661
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication39d920a0-9aa0-43c6-af47-caa86a0b1842
relation.isAuthorOfPublicationcd5e6220-0819-4b44-96be-971de0cf304e
relation.isAuthorOfPublication.latestForDiscoverycd5e6220-0819-4b44-96be-971de0cf304e
relation.isProjectOfPublication42e7489e-c853-4910-8d8d-0d9f9df0ffda
relation.isProjectOfPublication.latestForDiscovery42e7489e-c853-4910-8d8d-0d9f9df0ffda

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Medication use for the management of professional performance_between invisibility and social normalization.pdf
Size:
2.11 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections